Number of Cancer Survivors in U.S. Reaches 11.7 Million
The number of cancer survivors in the United States had increased to nearly 12 million by 2007, according to a report in the March 11 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
THURSDAY, March 10 (HealthDay News) -- The number of cancer survivors in the United States had increased to nearly 12 million by 2007, according to a report in the March 11 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
The CDC and the National Cancer Institute evaluated cancer incidence and follow-up information from nine Surveillance, Epidemiology, and End Results programs to estimate the number of individuals in the United States ever diagnosed with cancer who were alive on Jan. 1, 2007.
The data revealed that the number of cancer survivors increased from 9.8 million in 2001 to 11.7 million -- or 3.9 percent of the U.S. population -- in 2007. Breast, prostate, and colorectal cancers accounted for 51 percent of diagnoses among survivors. The data also revealed that an estimated 64.8 percent of cancer survivors had lived at least five years after their diagnosis of cancer and 59.5 percent of survivors were aged 65 years or older as of Jan. 1, 2007. In addition, women made up 54.3 percent of cancer survivors, and 4.7 million of all survivors received their diagnosis 10 or more years earlier.
"Because many cancer survivors live long after diagnosis and the U.S. population is aging, the number of persons living with a history of cancer is expected to continue to increase," the authors write. "Public health and health care professionals should understand the potential long-term needs of cancer survivors, engage in health promotion (e.g., urging cancer screening and smoking cessation), and ensure coordination of follow-up care for this growing population."
Related Content
- Gynecologic Oncology
- Annual Meeting on Women's Cancer(SGO) Oncology – 2011
- Breast Cancer
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
